Allspring Global Investments Holdings, LLC Halozyme Therapeutics, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$53.9 Billion
Q1 2025

A detailed history of Allspring Global Investments Holdings, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 40,917 shares of HALO stock, worth $2.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,917

Previous 46,527 12.06%

Holding current value

$2.17 Million

Previous $2.22 Million 17.36%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 24, 2025	SELL	$47.74 - $65.16 $267,821 - $365,547	-5,610 Reduced 12.06%	40,917 $2.61 Million
Q4 2024 Jan 29, 2025	SELL	$42.57 - $61.09 $23.7 Million - $34 Million	-556,772 Reduced 92.29%	46,527 $2.22 Million
Q3 2024 Oct 18, 2024	SELL	$51.3 - $64.42 $4.08 Million - $5.12 Million	-79,548 Reduced 11.65%	603,299 $34.5 Million
Q2 2024 Jul 26, 2024	SELL	$37.81 - $52.4 $502,116 - $695,872	-13,280 Reduced 1.91%	682,847 $35.8 Million
Q1 2024 Apr 18, 2024	SELL	$33.68 - $41.95 $1.07 Million - $1.34 Million	-31,871 Reduced 4.38%	696,127 $28.3 Million
Q4 2023 Jan 25, 2024	SELL	$33.32 - $42.1 $5.31 Million - $6.71 Million	-159,276 Reduced 17.95%	727,998 $26.9 Million
Q3 2023 Oct 27, 2023	BUY	$36.46 - $44.03 $32.4 Million - $39.1 Million	887,274 New	887,274 $33.9 Million
Q2 2023 Jul 18, 2023	BUY	$30.28 - $38.74 $2.44 Million - $3.12 Million	80,582 Added 33.2%	323,285 $11.7 Million
Q1 2023 Apr 13, 2023	SELL	$32.86 - $55.7 $5.11 Million - $8.66 Million	-155,513 Reduced 39.05%	242,703 $9.27 Million
Q4 2022 Jan 23, 2023	SELL	$40.06 - $59.44 $13.8 Million - $20.5 Million	-345,471 Reduced 46.45%	398,216 $0
Q3 2022 Oct 26, 2022	BUY	$38.53 - $51.78 $4.53 Million - $6.09 Million	117,645 Added 18.79%	743,687 $29.4 Million
Q2 2022 Jul 25, 2022	SELL	$37.35 - $48.3 $2.72 Million - $3.52 Million	-72,862 Reduced 10.43%	626,042 $27.5 Million
Q1 2022 May 02, 2022	SELL	$31.97 - $41.06 $6.11 Million - $7.84 Million	-191,033 Reduced 21.47%	698,904 $27.9 Million
Q4 2021 Jan 28, 2022	BUY	$31.82 - $40.75 $28.3 Million - $36.3 Million	889,937 New	889,937 $35.8 Million

Others Institutions Holding HALO

# of Institutions

594

Shares Held

124M

Call Options Held

320K

Put Options Held

113K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.37B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account

Allspring Global Investments Holdings, LLC Halozyme Therapeutics, Inc. Transaction History